Sophie Guelfi

Sophie Guelfi

Auto-generated profile, based on publicly available information

Sophie Guelfi

Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
SGSophie Guelfi
Sophie Guelfi
KHKairbaan Hodivala-Dilke
Kairbaan Hodivala-Dilke
GBGabriele Bergers
Gabriele Bergers

1 January 2016 in Stem Cells International
Verified
Journal Article
Open access
PDF file
SGSophie Guelfi
Sophie Guelfi
HDHugues Duffau
Hugues Duffau
LBLuc Bauchet
Luc Bauchet
BRBernard Rothhut
Bernard Rothhut
JHJean-Philippe Hugnot
Jean-Philippe Hugnot
Glioblastomas are devastating and extensively vascularized brain tumors from which glioblastoma stem‐like cells (GSCs) have been isolated by many groups. These cells have a high tumorigenic potential and the capacity to generate heterogeneous phenotypes. There is growing evidence to support the possibility that these cells are derived from the accumulation of mutations in adult neural stem cells (NSCs) as well as in oligodendrocyte progenitors. It was recently reported that GSCs could transdifferentiate into endothelial‐like and pericyte‐like cells both in vitro and in vivo, notably under the influence of Notch and TGFβ signaling pathways. Vascular cells derived from GBM cells were also observed directly in patient samples. These results could lead to new directions for designing original therapeutic approaches against GBM neovascularization but this specific reprogramming requires further molecular investigations. Transdifferentiation of nontumoral neural stem cells into vascular cells has also been described and conversely vascular cells may generate neural stem cells. In this review, we present and discuss these recent data. As some of them appear controversial, further validation will be needed using new technical approaches such as high throughput profiling and functional analyses to avoid experimental pitfalls and misinterpretations.

24 October 2025 in Science Advances
Verified
Journal Article
Open access
SGSophie Guelfi
Sophie Guelfi
KGKrish Skandha Gopalan
Krish Skandha Gopalan
PMPieter Maene
Pieter Maene
DRDorothy John Robbert
Dorothy John Robbert
CPCarla Pallarés-Moratalla
Carla Pallarés-Moratalla
GBGabriele Bergers
Gabriele Bergers
Blood vascular organoids (BVOs) have emerged as powerful tools for interrogating endothelial heterogeneity, function, and organ-specific cues during development, homeostasis, and disease. Here, we describe the stepwise generation and characterization of murine BVOs from different embryonic stem cells and introduce a fluorescent tracer system to follow their formation and maturation, visualizing functional and perfused vessels after transplantations into mice. Single-cell RNA sequencing, FACS, and whole-mount immunohistochemistry revealed a heterogeneous and dynamic trajectory of multiple endothelial, mesenchymal, and macrophage clusters in mBVOs at growth spike and full maturation. Endothelial cells inferred high plasticity toward arterial, venous, capillary, and tip/stalk cells and a neural-like identity at full maturation state. mBVOs responded to inflammatory cues and VEGF blockade in vitro and could be assembled with tumor spheroids in which tumor cells mimicked the same vascular growth pattern as observed in vivo. Our results highlight mBVOs as adaptable in vitro platforms, unlocking various applications and avenues for discovery in vascular biology.